Intranasal Vaccines
Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines
Chad Costley, M.D.
BlueWillow Biologics
PAO-04-022-CL-15Apr 28, 2022
Critical Care
Bringing Novel Solutions to Market for Unmet Needs
David Alvaro, Ph.D.; Leonard Mazur
Pharma's Almanac
PAO-04-022-CL-06Apr 25, 2022
Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Robert Clarke, Ph.D
Kinaset Therapeutics
PAO-02-022-CL-13Mar 12, 2022
Long COVID
Modernizing Respiratory Care with a Focus on Long COVID
VIDA Diagnostics
PAO-02-22-R250-23Feb 28, 2022
Decentralized Clinical Trials
A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research
Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.; Jenna McDonnell; Tim Rich
PPD clinical research business of Thermo Fisher Scientific
PAO-10-21-CL-04Oct 12, 2021
Drug Development
HPV Treatment May Also Fight Rare Respiratory Disease
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-009Apr 10, 2019
Respiratory
Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor
Theravance Biopharma
PR-M11-18-NI-102Nov 29, 2018
Respiratory
Gala Enrolls First Subjects in an Early Feasibility Study of RheOx™ for Chronic Bronchitis in the United States
Gala Therapeutics
PR-M11-18-NI-023Nov 7, 2018
New Facility
GSK Opens New Facility in Scotland
Emilie Branch
Pharma's Almanac
PAO-M11-18-NI-007Nov 5, 2018
EU Approves AstraZeneca’s Respiratory Biologic
Nigel Walker
Nice Insight
PAO-M01-18-NI-031Jan 18, 2018